1 completed, 1 not yet recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Dexamethasone (Oral): new trials by email Literature Review of Dexamethasone (Oral) trials Research Report on Dexamethasone (Oral)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DiEtary Mimicry by Glucocorticoid Modulation Evaluation in ER+ Metastatic Breast Cancer Treatment: Efficacy and Response (DEMETER Trial) Dexamethasone (Oral) - Breast Cancer | Phase 2 | Not yet recruiting | The Netherlands Cancer Institute | 80 | 2026-11-01 | 2026-08-25 |
| Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma Lenalidomide, Dexamethasone, Dexamethasone (Oral) - Lymphoma, Multiple Myeloma | Phase 3 | Completed | Bristol-Myers Squibb | 646 | 2011-06-20 | 2022-06-01 |
Breast Neoplasms (1) · Lymphoma (1) · Multiple Myeloma (1)
Bristol-Myers Squibb (1) · The Netherlands Cancer Institute (1)
Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Ireland (1) · Israel (1) · Italy (1) · Japan (1) · Poland (1)